BDX — BCAL Diagnostics Share News
0.000.00%
Last trade - 00:00- AU$27.65m
- AU$32.98m
- AU$2.55m
Brief: BCAL Diagnostics Introduces Avantect Multi-Cancer Early Detection Test
Brief: BCAL Diagnostics Clarifies Of Bcal's Position In Relation To Genetic Signatures
Brief: Genetic Signatures Requested BCAL Diagnostics To Clarify Details Of Shareholdings, Associates In Co
Brief: BCAL To Acquire Shares In Genetic Signatures
Brief: Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility
Australia's BCAL Diagnostics soars on development of new blood test for breast cancer
Brief: BCAL Diagnostics Says Validation Agreement Signed With Sonic USA, For Breastest V2
Australia's BCAL Diagnostics launches early detection cancer platform, shares rise
Brief: BCAL Diagnostics Launches Early Detection Cancer Platform
Brief: Bcal Diagnostics Appoints Anne-Louise Arnett As CEO
Brief: BCAL Diagnostics Submits MSAC Application For Avantect Pancreatic Cancer Early Detection Blood Test
Bcal Diagnostics Hits 9: month high on ethics approval in Australia
Brief: BCAL Diagnostics Establishes A$10 Million Convertible Note Facility
Brief: BCAL Diagnostics Enters Into Exclusive Licence Agreement With Clearnote Health
Australia's BCAL Diagnostics rises on licence agreement with US-based firm
Brief: BCAL Diagnostics Posts FY Net Loss Attributable A$7.2 Million
Australia's BCAL Diagnostics rises on partnership with Sonic Healthcare's unit
Brief: Bcal Diagnostics Partners With Sonic Healthcare
Australia's BCAL Diagnostics jumps on partnership with private oncology network